Crispo, F.; Vassallo, A.; Faraone, I.; Santarsiere, A.; Chiummiento, L.; Martinelli, M.; Cascelli, N.; Fernà ndez-Busquets, X.; Miglionico, R.; Nigro, I.;
et al. Repurposing HIV-Protease Inhibitor Precursors as Anticancer Agents: The Synthetic Molecule RDD-142 Delays Cell Cycle Progression and Induces Autophagy in HepG2 Cells with Enhanced Efficacy via Liposomal Formulation. Int. J. Mol. Sci. 2025, 26, 10305.
https://doi.org/10.3390/ijms262110305
AMA Style
Crispo F, Vassallo A, Faraone I, Santarsiere A, Chiummiento L, Martinelli M, Cascelli N, Fernà ndez-Busquets X, Miglionico R, Nigro I,
et al. Repurposing HIV-Protease Inhibitor Precursors as Anticancer Agents: The Synthetic Molecule RDD-142 Delays Cell Cycle Progression and Induces Autophagy in HepG2 Cells with Enhanced Efficacy via Liposomal Formulation. International Journal of Molecular Sciences. 2025; 26(21):10305.
https://doi.org/10.3390/ijms262110305
Chicago/Turabian Style
Crispo, Fabiana, Antonio Vassallo, Immacolata Faraone, Alessandro Santarsiere, Lucia Chiummiento, Mara Martinelli, Nicoletta Cascelli, Xavier Fernà ndez-Busquets, Rocchina Miglionico, Ilaria Nigro,
and et al. 2025. "Repurposing HIV-Protease Inhibitor Precursors as Anticancer Agents: The Synthetic Molecule RDD-142 Delays Cell Cycle Progression and Induces Autophagy in HepG2 Cells with Enhanced Efficacy via Liposomal Formulation" International Journal of Molecular Sciences 26, no. 21: 10305.
https://doi.org/10.3390/ijms262110305
APA Style
Crispo, F., Vassallo, A., Faraone, I., Santarsiere, A., Chiummiento, L., Martinelli, M., Cascelli, N., Fernà ndez-Busquets, X., Miglionico, R., Nigro, I., Caddeo, C., & Armentano, M. F.
(2025). Repurposing HIV-Protease Inhibitor Precursors as Anticancer Agents: The Synthetic Molecule RDD-142 Delays Cell Cycle Progression and Induces Autophagy in HepG2 Cells with Enhanced Efficacy via Liposomal Formulation. International Journal of Molecular Sciences, 26(21), 10305.
https://doi.org/10.3390/ijms262110305
